focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-EU tries to restrict vaccine exports to UK with emergency Brexit rules

Fri, 29th Jan 2021 19:28

* EU triggers emergency Brexit clauses

* EU tries to restrict vaccine exports to UK

* UK seeks urgent answers

* Irish PM expresses concerns to EU chief
(Adds reaction, details)

By Andy Bruce and Kate Holton

LONDON, Jan 29 (Reuters) - The European Union on Friday
sought to restrict exports of COVID-19 vaccines to Northern
Ireland by overriding a part of the post-Brexit deal with
Britain, a steep escalation of the bloc's battle to secure
vaccine supplies.

Northern Ireland First Minister Arlene Foster described as
"an incredible act of hostility" the decision by the EU to
invoke Article 16 of the Northern Irish Protocol, which allows
Britain or the EU to take unilateral action if there is an
unexpected negative effect arising from the agreement.

A spokesman for the British government said senior cabinet
minister Michael Gove had expressed to the EU "concern over a
lack of notification", and said it would be "carefully
considering next steps".

The EU move is designed to prevent the open border between
EU-member Ireland and Northern Ireland from acting as a backdoor
for vaccine supplies into the United Kingdom.

It was not immediately clear if the move to invoke the
article, set out in a document published on Friday, would come
into effect immediately. A link to the document was no longer
working at 2050 GMT.

Article 16 was devised as a last resort to alleviate serious
disruption to trade in Northern Ireland after Brexit.

The EU, whose member states are far behind Israel, Britain
and the United States in rolling out vaccines, is scrambling to
get supplies just as the West's biggest drugmakers slow
deliveries to the bloc due to production problems.

The British-Swedish drugmaker AstraZeneca has been
caught in the crosshairs after it said last week it would fall
short of delivering promised vaccines to the EU by March because
of production problems in Belgium.

That has angered Brussels which has demanded to know why it
cannot divert supplies from its British sites which have been
producing millions of shots for British citizens.

The European Commission has agreed a plan to control exports
of vaccines from the bloc, including to Britain, arguing it
needed to do so to ensure its own supplies.

The Commission said its move to invoke Article 16 was
justified to "avert serious societal difficulties" in EU states
due to a lack of vaccine supply, the document published on
Friday said.

Britain has its own domestic supply chain in place for
AstraZeneca's shot, including rolling it out in Northern
Ireland, but it imports Pfizer's vaccine from a factory in
Belgium.

Ireland's Prime Minister Micheál Martin expressed concern to
EU chief Ursula von der Leyen over the executive's decision.

Northern Ireland's Foster went further. "This is an
incredible act of hostility," she said.

"By triggering Article 16 in this manner, the European Union
has once again shown it is prepared to use Northern Ireland when
it suits their interests but in the most despicable manner –
over the provision of a vaccine which is designed to save
lives."

Britain had threatened to trigger the Article 16 safeguard
measures earlier in the month if there were "serious problems"
in supplying supermarkets in Northern Ireland.
(Reporting by Kate Holton, Andy Bruce and William James;
Editing by Guy Faulconbridge)

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.